We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRisedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study.AuthorsIzumi, K; Mizokami, A; Sugimoto, K; Narimoto, K; Kitagawa, Y; Koh, E; Namiki, MPublicationProstate Cancer & Prostatic Diseases, 2011, Vol 14, Issue 3, p238ISSN1365-7852Publication typearticleDOI10.1038/pcan.2011.10